Zhang, Jason Z. http://orcid.org/0000-0003-0091-6273
Yeh, Hsien-Wei http://orcid.org/0000-0002-9023-776X
Walls, Alexandra C. http://orcid.org/0000-0002-9636-8330
Wicky, Basile I. M. http://orcid.org/0000-0002-2501-7875
Sprouse, Kaitlin R. http://orcid.org/0000-0003-0007-2226
VanBlargan, Laura A. http://orcid.org/0000-0002-8922-8946
Treger, Rebecca
Quijano-Rubio, Alfredo http://orcid.org/0000-0003-1567-9530
Pham, Minh N.
Kraft, John C. http://orcid.org/0000-0002-7931-7478
Haydon, Ian C. http://orcid.org/0000-0001-7227-9811
Yang, Wei
DeWitt, Michelle
Bowen, John E.
Chow, Cameron M. http://orcid.org/0000-0001-5351-6412
Carter, Lauren
Ravichandran, Rashmi
Wener, Mark H. http://orcid.org/0000-0002-8304-6957
Stewart, Lance http://orcid.org/0000-0003-4264-5125
Veesler, David http://orcid.org/0000-0002-6019-8675
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Greninger, Alexander L.
Koelle, David M.
Baker, David http://orcid.org/0000-0001-7896-6217
Funding for this research was provided by:
European Molecular Biology Organization (ALTF 139-2018)
Bill and Melinda Gates Foundation (OPP1156262)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM120553)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (DP1AI158186, HHSN272201700059C, AI201800007, U01AI151698-01)
Burroughs Wellcome Fund
U.S. Department of Health & Human Services | National Institutes of Health (R01AI17155)
Article History
Received: 3 June 2021
Accepted: 14 March 2022
First Online: 28 April 2022
Competing interests
: D.B., A.Q.-R., H.-W. Y. and L.S. are co-inventors in a provisional patent application (PCT/US2021/034104) covering the SARS-CoV-2 RBD biosensor described in this article. M.S.D. is a consultant for Inbios, Vir Biotechnology and Fortress Biotech and on the Scientific Advisory Boards of Moderna and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology and Emergent BioSolutions. The Veesler laboratory has received unrelated funding support in sponsored research agreement from Vir Biotechnology.